Literature DB >> 23780744

Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides.

Nina Bionda1, Renee M Fleeman, Lindsey N Shaw, Predrag Cudic.   

Abstract

Cyclic lipopeptides derived from the fusaricidin/LI-F family of naturally occurring antibiotics represent particularly attractive candidates for the development of new antibacterial agents. In comparison with natural products, these derivatives may offer better stability under physiologically relevant conditions and lower nonspecific toxicity, while preserving their antibacterial activity. In this study we assessed the ability of cyclic lipodepsipeptide 1 and its analogues--amide 2, N-methylamide 3, and linear peptide 4--to interact with the cytoplasmic membranes of selected Gram-positive bacteria. We also investigated their bacteriostatic/bactericidal modes of action and in vivo potency by using a Galleria mellonella model of MRSA infection. Cyclic lipopeptides 1 and 2 depolarize the cytoplasmic membranes of Gram-positive bacteria in a concentration-dependent manner. The degree of membrane depolarization was influenced by the structural and physical properties of 1 and 2, with the more flexible and hydrophobic peptide 1 being most efficient. However, membrane depolarization does not correlate with bacterial cell lethality, suggesting that membrane-targeting activity is not the main mode of action for this class of antibacterial peptides. Conversely, substitution of the depsipeptide bond in 1 with an N-methylamide bond in 3, or its hydrolysis to peptide 4, lead to a complete loss of antibacterial activity and indicate that the conformation of cyclic lipopeptides plays a role in their antibacterial activities. Cyclic lipopeptides 1 and 2 are also capable of improving the survival of G. mellonella larvae infected with MRSA at varying efficiencies, reflecting their in vitro activities. Gaining more insight into the structure-activity relationship and mode of action of these cyclic lipopeptides may enable the development of new antibiotics of this class with improved antibacterial activity.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; biological activity; depsipeptides; isosteric analogues; membranes

Mesh:

Substances:

Year:  2013        PMID: 23780744      PMCID: PMC3787707          DOI: 10.1002/cmdc.201300173

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  47 in total

Review 1.  Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity.

Authors:  N Sitaram; R Nagaraj
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.

Authors:  M Wu; R E Hancock
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

3.  Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents.

Authors:  Anna C Jacobs; Louis Didone; Jennielle Jobson; Madeline K Sofia; Damian Krysan; Paul M Dunman
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

4.  Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria.

Authors:  C L Friedrich; D Moyles; T J Beveridge; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

5.  Genetic basis for in vivo daptomycin resistance in enterococci.

Authors:  Cesar A Arias; Diana Panesso; Danielle M McGrath; Xiang Qin; Maria F Mojica; Corwin Miller; Lorena Diaz; Truc T Tran; Sandra Rincon; E Magda Barbu; Jinnethe Reyes; Jung H Roh; Elizabeth Lobos; Erica Sodergren; Renata Pasqualini; Wadih Arap; John P Quinn; Yousif Shamoo; Barbara E Murray; George M Weinstock
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

6.  Fusaricidin A, a new depsipeptide antibiotic produced by Bacillus polymyxa KT-8. Taxonomy, fermentation, isolation, structure elucidation and biological activity.

Authors:  Y Kajimura; M Kaneda
Journal:  J Antibiot (Tokyo)       Date:  1996-02       Impact factor: 2.649

7.  Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  N-methylation of peptides: a new perspective in medicinal chemistry.

Authors:  Jayanta Chatterjee; Chaim Gilon; Amnon Hoffman; Horst Kessler
Journal:  Acc Chem Res       Date:  2008-07-18       Impact factor: 22.384

9.  Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model.

Authors:  M W Garrison; K Vance-Bryan; T A Larson; J P Toscano; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

10.  On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.

Authors:  Tina R White; Chad M Renzelman; Arthur C Rand; Taha Rezai; Cayla M McEwen; Vladimir M Gelev; Rushia A Turner; Roger G Linington; Siegfried S F Leung; Amit S Kalgutkar; Jonathan N Bauman; Yizhong Zhang; Spiros Liras; David A Price; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

View more
  5 in total

1.  Consequences of Depsipeptide Substitution on the ClpP Activation Activity of Antibacterial Acyldepsipeptides.

Authors:  Yangxiong Li; Nathan P Lavey; Jesse A Coker; Jessica E Knobbe; Dat C Truong; Hongtao Yu; Yu-Shan Lin; Susan L Nimmo; Adam S Duerfeldt
Journal:  ACS Med Chem Lett       Date:  2017-10-19       Impact factor: 4.345

2.  Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities.

Authors:  Nina Bionda; Renee M Fleeman; César de la Fuente-Núñez; Maria C Rodriguez; Fany Reffuveille; Lindsey N Shaw; Irena Pastar; Stephen C Davis; Robert E W Hancock; Predrag Cudic
Journal:  Eur J Med Chem       Date:  2015-11-30       Impact factor: 6.514

3.  Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE).

Authors:  Christoph Lübbert; Arne C Rodloff; Kamal Hamed
Journal:  Infect Dis Ther       Date:  2015-07-14

4.  Synthesis and Evaluation of Antimycobacterial and Antiplasmodial Activities of Hirsutellide A and Its Analogues.

Authors:  Henok Asfaw Sahile; Maria Santos Martínez-Martínez; Melissa Dillenberger; Katja Becker; Peter Imming
Journal:  ACS Omega       Date:  2020-06-09

5.  Preclinical Assessment of a 68Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent.

Authors:  Thomas Ebenhan; Botshelo Brenda Mokaleng; Jacobus Daniel Venter; Hendrik Gert Kruger; Jan Rijn Zeevaart; Mike Sathekge
Journal:  Molecules       Date:  2017-08-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.